scPharmaceuticals Inc.
SCPH · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $16,041 | $11,752 | $12,150 | $10,026 |
| % Growth | 36.5% | -3.3% | 21.2% | – |
| Cost of Goods Sold | $5,011 | $3,471 | $3,965 | $3,311 |
| Gross Profit | $11,030 | $8,281 | $8,185 | $6,715 |
| % Margin | 68.8% | 70.5% | 67.4% | 67% |
| R&D Expenses | $4,098 | $4,631 | $3,154 | $3,541 |
| G&A Expenses | $0 | $0 | $1,075 | $0 |
| SG&A Expenses | $21,226 | $21,407 | $21,374 | $21,320 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $25,324 | $26,038 | $24,528 | $24,861 |
| Operating Income | -$14,294 | -$17,757 | -$16,343 | -$18,146 |
| % Margin | -89.1% | -151.1% | -134.5% | -181% |
| Other Income/Exp. Net | -$3,730 | -$1,985 | -$2,502 | -$16,959 |
| Pre-Tax Income | -$18,024 | -$19,742 | -$18,845 | -$35,105 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$18,024 | -$19,742 | -$18,845 | -$35,105 |
| % Margin | -112.4% | -168% | -155.1% | -350.1% |
| EPS | -0.34 | -0.37 | -0.42 | -0.75 |
| % Growth | 8.1% | 11.9% | 44% | – |
| EPS Diluted | -0.34 | -0.37 | -0.42 | -0.75 |
| Weighted Avg Shares Out | 53,720 | 53,676 | 44,520 | 46,558 |
| Weighted Avg Shares Out Dil | 53,720 | 53,676 | 44,520 | 46,558 |
| Supplemental Information | – | – | – | – |
| Interest Income | $509 | $716 | $1,000 | $903 |
| Interest Expense | $1,401 | $1,385 | $1,485 | $1,850 |
| Depreciation & Amortization | $64 | $63 | -$16 | -$87 |
| EBITDA | -$16,559 | -$18,294 | -$17,299 | -$33,250 |
| % Margin | -103.2% | -155.7% | -142.4% | -331.6% |